Termination of Material Agreement (Form 8-K)

Item 1.02 Termination of a Material Definitive Agreement.

As previously disclosed, on June 6, 2025, Advanced Biomed Inc. (the "Company") entered into a purchase agreement (the "Purchase Agreement") with Helena Global Investment Opportunities I Ltd. (the "Investor"), pursuant to which the Company had the right, but not the obligation, to issue and sell to the Investor, from time to time at the Company's sole discretion, up to $25,000,000 of shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), subject to the terms, conditions and limitations set forth in the Purchase Agreement.

On July 14, 2026, the Company delivered to the Investor a written notice of termination of the Purchase Agreement (the "Termination Notice") pursuant to Section 11.02(b) of the Purchase Agreement, which permits the Company to terminate the Purchase Agreement upon five (5) trading days' prior written notice to the Investor, provided that (i) there are no outstanding Advance Notices (as defined in the Purchase Agreement) in respect of which shares of Common Stock have yet to be issued and (ii) the Company has paid all amounts owed to the Investor pursuant to the Purchase Agreement, including all Commitment Fee Shares (as defined in the Purchase Agreement).

As of the date of the Termination Notice, there were no outstanding Advance Notices under the Purchase Agreement, and the Company had paid all amounts owed to the Investor pursuant to the Purchase Agreement, including the issuance of all Commitment Fee Shares. As of the date of this Current Report on Form 8-K, the Company has not issued or sold any shares of Common Stock to the Investor pursuant to any Advance under the Purchase Agreement, other than the Commitment Fee Shares. In accordance with Section 11.02(b) of the Purchase Agreement, the termination of the Purchase Agreement will become effective on July 21, 2026.

The foregoing description of the Purchase Agreement does not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement, a copy of which was filed as Exhibit 99.1 to the Company's Report on Form 6-K filed with the U.S. Securities and Exchange Commission on June 6, 2025, and is incorporated herein by reference.